Dr. Benjamin Oshrine
Claim this profileJohns Hopkins All Children's Hospital
Affiliated Hospitals
Johns Hopkins All Children's Hospital
Johns Hopkins All Childrens
Clinical Trials Benjamin Oshrine is currently running
Reduced Intensity BMT
for Solid Cancer
The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and shortened duration tacrolimus is safe and feasible for patients with very high-risk solid tumors.
Recruiting
1 award
Phase 2
28 criteria
Nivolumab After Bone Marrow Transplant
for Sarcoma
This research is being done to find out if an investigational drug, Nivolumab, can be safely administered after a "half-matched" (haplo) bone marrow transplant (BMT), and if the investigational drug will help to prevent or delay relapse or progression of sarcomas. In this study investigators will also be trying to learn more about how the investigational drug changes blood and/or tumors. Participants are eligible for this trial if they have recently undergone a "half-matched" (haplo) bone marrow transplant and have either relapsed or are at high risk to relapse.
Recruiting
1 award
Phase 1 & 2
More about Benjamin Oshrine
Clinical Trial Related
7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Benjamin Oshrine has experience with
- Tisagenlecleucel
- Vorinostat
- Azacitidine Injection
- Lactobacillus Plantarum
- Nivolumab
- Fludarabine
Breakdown of trials Benjamin Oshrine has run
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Oshrine specialize in?
Benjamin Oshrine focuses on Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are undergoing treatment.
Is Benjamin Oshrine currently recruiting for clinical trials?
Yes, Benjamin Oshrine is currently recruiting for 4 clinical trials in Saint Petersburg Florida. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Oshrine has studied deeply?
Yes, Benjamin Oshrine has studied treatments such as Tisagenlecleucel, Vorinostat, Azacitidine Injection.
What is the best way to schedule an appointment with Benjamin Oshrine?
Apply for one of the trials that Benjamin Oshrine is conducting.
What is the office address of Benjamin Oshrine?
The office of Benjamin Oshrine is located at: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida 33701 United States. This is the address for their practice at the Johns Hopkins All Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.